Guanidine,N-[3-[3,7-dihydro-6-(1H-indol-3-yl)-2-(1-methylpropyl)-3-oxoimidazo[1,2-a]pyrazin-8-yl]propyl]-,hydrobromide (1:2) (23510-45-4)

Identification
Name:	Guanidine,N-[3-[3,7-dihydro-6-(1H-indol-3-yl)-2-(1-methylpropyl)-3-oxoimidazo[1,2-a]pyrazin-8-yl]propyl]-,hydrobromide (1:2)
CAS:	23510-45-4
Molecular Formula:	C22H27 N7 O . 2 Br H
Molecular Weight:	567.32
InChI:	InChI=1/C22H27N7O.2BrH/c1-3-13(2)19-21(30)29-12-18(15-11-26-16-8-5-4-7-14(15)16)27-17(20(29)28-19)9-6-10-25-22(23)24;;/h4-5,7-8,11-13,26-27H,3,6,9-10H2,1-2H3,(H4,23,24,25);2*1H
Molecular Structure:
Properties
Flash Point:	332.4°C
Boiling Point:	626°Cat760mmHg
Density:	g/cm³
Flash Point:	332.4°C
Safety Data

Other Product

Guanidine,[3-[3,7-dihydro-6-(1H-indol-3-yl)-2-(1-methylpropyl)-3-oxoimidazo[1,2-a]pyrazin-8-yl]propyl]-
Guanidine,N-[3-(1,2-dihydro-2-methyl-1-oxopyrrolo[1,2-a]pyrazin-3-yl)propyl]-
Benzonitrile, 4-(3,7-dihydro-7-methyl-3-oxoimidazo[1,2-a]pyrazin-2-yl)-
Thiourea,N-[2-[4-(3,7-dihydro-2-methyl-3-oxoimidazo[1,2-a]pyrazin-6-yl)phenoxy]ethyl]-N'-(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)-, sodium salt (1:1)
1-[3-[1,6-Dihydro-5-(2-methylpropyl)-6-oxopyrazin-1-yl]propyl]guanidine
Furo[3,4-b]pyrazin-5(7H)-one,7-(1-ethyl-2-methyl-1H-indol-3-yl)-7-(2-methyl-1-propyl-1H-indol-3-yl)-2,3-diphenyl-
Furo[3,4-b]pyrazin-5(7H)-one,7-(1-ethyl-2-methyl-1H-indol-3-yl)-2,3-dimethyl-7-(2-methyl-1-propyl-1H-indol-3-yl)-
6-(1-Methylpropyl)-3-(2-methylpropyl)pyrazin-2(1H)-one
1-hydroxy-6-(2-hydroxybutan-2-yl)-3-(2-methylpropyl)pyrazin-2(1H)-one
Guanidine,N-[3-[3-amino-6-(1H-indol-3-yl)-2-pyrazinyl]propyl]-
Guanidine,N-[3-[3-[2,5-dihydro-4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-1H-pyrrol-3-yl]-1H-indol-1-yl]propyl]-N'-nitro-(9CI)
1H-Indene-1,3(2H)-dione,2-[(2S)-2,3-dihydro-2-(1-methylethyl)-3-oxoimidazo[1,2-c]quinazolin-5-yl]-
2H-Indol-2-one,1,3-dihydro-7-hydroxy-4-(1-propyl-3-piperidinyl)-, hydrobromide (1:1)
Furo[3,4-b]pyrazin-5(7H)-one,7-[4-(diethylamino)phenyl]-7-(1-ethyl-2-methyl-1H-indol-3-yl)-2-methyl-3-propyl-
1H-Indene-1,3(2H)-dione,2-[(2S)-2,3-dihydro-2-(2-methylpropyl)-3-oxoimidazo[1,2-c]quinazolin-5-yl]-
Ergoline-8-carboxamide,9,10-didehydro-6- methyl-N-[(1S)-2-methyl-1-[[(3S,8aR)-tetrahydro- 3-(2-methylpropyl)-1,4-dioxopyrrolo[1,- 2-a]pyrazin-2(3H)-yl]carbonyl]propyl]-,(8â)-
Furo[3,4-b]pyrazin-5(7H)-one,7-(1-butyl-2-methyl-1H-indol-3-yl)-7-(1-ethyl-2-methyl-1H-indol-3-yl)-2,3-diphenyl-
Furo[3,4-b]pyrazin-5(7H)-one,7-(1-ethyl-2-methyl-1H-indol-3-yl)-7-(2-methyl-1-octyl-1H-indol-3-yl)-2,3-diphenyl-
Furo[3,4-b]pyrazin-5(7H)-one,7-(1-ethyl-2-methyl-1H-indol-3-yl)-7-(1-ethyl-2-phenyl-1H-indol-3-yl)-2,3-diphenyl-
Furo[3,4-b]pyrazin-5(7H)-one,7-(1-butyl-2-methyl-1H-indol-3-yl)-7-(1-ethyl-2-methyl-1H-indol-3-yl)-2,3-dimethyl-